| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/01/2006 | CN1739681A Medicine for treating cancer and its prepn process |
| 03/01/2006 | CN1739676A Chinese medicine mixture for treating leucopenia caused by tumor treating radiation therapy and chemotherapy and its quality control method |
| 03/01/2006 | CN1739626A Tea extract dripping pill |
| 03/01/2006 | CN1739613A Tumor treating medicine |
| 03/01/2006 | CN1739607A Common lamiophlomis root dripping pill and its prepn process |
| 03/01/2006 | CN1739601A Anticancer Chinese medicine prepn and its prepn process |
| 03/01/2006 | CN1739586A Extraction process and application in preparing anticancer medicine of sugar apple seed extract |
| 03/01/2006 | CN1739577A Cancer treating Chinese medicine prepn |
| 03/01/2006 | CN1739562A Application of metal fullerol in inhibiting tumor growth |
| 03/01/2006 | CN1739548A Omithogalum caudatum polysaccharide medicine for treating liver cancer |
| 03/01/2006 | CN1739546A Use of skullcap aglycone and baicalin in preparing antitumor medicine |
| 03/01/2006 | CN1739543A Intravenous injection of antitumor compound nobiliside A and monoacetylated liposome and its prepn |
| 03/01/2006 | CN1739515A Hydroxycamptothecine injection and its prepn process |
| 03/01/2006 | CN1739510A Use of sophoridine oxide in preparing anticancer medicine |
| 03/01/2006 | CN1739509A Composite medicine for treating tumor and its application |
| 03/01/2006 | CN1739494A Orally taken self-microemulsified concentrate of all-trans vitamin A acid |
| 03/01/2006 | CN1243779C Hydrophilic polymer derivative having Y shaped branch, its preparation method, combined object with medicine molecule and medical composition containing combined object |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 03/01/2006 | CN1243746C Heterocyclic compound inhibiting angiogenesis |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243570C Anti-tumour magnetic targeted slow release carrier iron-carbon composite material and its preparation method |
| 03/01/2006 | CN1243564C Chinese medicinal powder for treating esophagus cancer |
| 03/01/2006 | CN1243561C Chinese medicine for treating cancer |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 03/01/2006 | CN1243549C Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method |
| 03/01/2006 | CN1243546C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 03/01/2006 | CN1243545C DNA-cleaving antitumor agents |
| 03/01/2006 | CN1243544C Taxusol composition and its preparing process |
| 03/01/2006 | CN1243538C Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method |
| 02/28/2006 | US7005526 Thioether derivatives |
| 02/28/2006 | US7005513 Made by conjugating a chemically decomposed natural glycosaminoglycan such as heparin and a vinylbenzylamine and then polymerizing the "vinylated" glycosaminoglycan; bind cell growth factors more effectively; use as antitumor agent or in assays |
| 02/28/2006 | US7005500 Nucleotide sequence coding polypeptide for use in the diagnosis of of neoplastic disorders |
| 02/28/2006 | US7005498 analogues of immunogenic human Her2 proteins comprising amino acid sequences modified foreign T-helper lymphocyte epitopes, used for immunotherapy |
| 02/28/2006 | US7005444 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005426 Complexes enter into cells via the pathway of the folic acid receptor on the cell membranes and then kill tumor cells in vivo and suppress the growth of tumor tissues without injuring normal cells; antitumor, -carcinogenic agents |
| 02/28/2006 | US7005424 Admininstering mixtures of anticarcinogenic agents and early genes for prophylaxis of cancer, tumors or metastasis; gene expression inhibitors |
| 02/28/2006 | US7005420 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005285 Human p21-activated kinase 5 polypeptide |
| 02/28/2006 | US7005279 Process for producing carbohydrates using β 1,3-N-acetyl-glucosaminyltransferase |
| 02/28/2006 | US7005255 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/28/2006 | US7005146 useful in treating cancer of relation type to the lymph node |
| 02/28/2006 | CA2486285A1 Immunoconjugates targeting syndecan-1 expressing cells and use thereof |
| 02/28/2006 | CA2332535C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2006 | CA2204204C Carbohydrate derivatives |
| 02/28/2006 | CA2123946C Cyclodextrin inclusion product of paclitaxel, process for producing the same, and its use |
| 02/23/2006 | WO2006021008A2 Ionophores as cancer chemotherapeutic agents |
| 02/23/2006 | WO2006021002A2 Compounds useful for inhibiting chk1 |
| 02/23/2006 | WO2006020979A2 Factor vii conjugates for selectively treating neovascularization disorders |
| 02/23/2006 | WO2006020719A2 Aminoacid conjugates of beta - lapachone for tumor targeting |
| 02/23/2006 | WO2006020684A2 Methods of regulating differentiation and treating of multiple myeloma |
| 02/23/2006 | WO2006020403A2 3-halo-2-oxopropionate salts and esters as novel anticancer agents |
| 02/23/2006 | WO2006019950A2 Conjugates of a gm-csf moiety and a polymer |
| 02/23/2006 | WO2006018723A2 Androgen modulators |
| 02/23/2006 | WO2006018657A1 Hdac inhibitors and methods of use thereof |
| 02/23/2006 | WO2006018649A1 Arene ruthenium (ii) compounds and their use in cancer therapy |
| 02/23/2006 | WO2006018632A2 Cell therapy with exo 1 |
| 02/23/2006 | WO2006018625A2 Peripheral benzodiazepine receptor independent superoxide generation |
| 02/23/2006 | WO2006018544A1 Composition containing a thiophenic or benzothiophenic compound and exhibiting a pump nora inhibiting activity |
| 02/23/2006 | WO2006018185A2 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | WO2005105062A3 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations |
| 02/23/2006 | WO2005069771A3 Small molecule antagonists of bcl-2 family proteins |
| 02/23/2006 | WO2005061538A3 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 02/23/2006 | WO2005004988A3 Compositions and methods relating to novel compounds and targets thereof |
| 02/23/2006 | WO2004078137A3 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/23/2006 | WO2004071458A3 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 02/23/2006 | WO2003072732A3 Methods of making hypermutable cells using pmsr homologs |
| 02/23/2006 | WO2003047523A3 Raf-mek-erk pathway inhibitors to treat cancer |
| 02/23/2006 | US20060041159 Transition metal complexes with proton sponges as ligands |
| 02/23/2006 | US20060041130 Syntheses of quinazolinones |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060040997 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
| 02/23/2006 | US20060040996 Administering compound such as 5 {[2-(dimethylamino)ethyl]amino}-2-methyl-1,3-benzothiazole-4,7-dione |
| 02/23/2006 | US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 02/23/2006 | US20060040990 Epothilone derivatives, process for their production, and their pharmaceutical use |
| 02/23/2006 | US20060040983 Quinolinyl-pyrrolopyrazoles |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040960 (3-amino-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-2-yl)-(2,5-dimethoxyphenyl)methanone; antiproliferative agent; solid tumors: breast, respiratory tract, brain, reproductive organs, digestive tract, liver, skin, head and neck, thyroid, and their metastases; lymphomas, sarcomas, and leukemias |
| 02/23/2006 | US20060040959 Adenosine A3 receptor modulators |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040943 3-Furanyl analogs of toxoflavine as kinase inhibitors |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040930 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same |
| 02/23/2006 | US20060040914 Meso-substituted porphyrins |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/23/2006 | US20060040903 Methods of use related to xerostomia |
| 02/23/2006 | US20060040891 Lipid a and other carbohydrate ligand analogs |
| 02/23/2006 | US20060040886 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040869 Pharmaceutically useful compounds |
| 02/23/2006 | US20060040853 Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 02/23/2006 | US20060040851 Gag-peptide complex |
| 02/23/2006 | US20060040850 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 02/23/2006 | US20060040358 IGF-1 receptor interacting proteins |
| 02/23/2006 | US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |